Skip to main content

Table 1 Distributions of demographic characteristics in hepatocellular carcinoma (HCC) patients and control subjects by study location

From: Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies

 

Non-Asians in Los Angeles, California

Chinese in southern Guangxi, China

Demographics

HCC patients (n = 117)

Control subjects (n = 225)

HCC patients (n = 250)

Control subjects (n = 245)

Age (years)

60.4

59.3

49.3

49.5

  2-sided P

0.37

0.87

Sex (%)

    

 Males

80 (68.4)

136 (60.4)

220 (88.0)

216 (88.2)

 Females

37 (31.6)

89 (39.6)

30 (12.0)

29 (11.8)

  2-sided P

0.15

0.96

Race/ethnicity (%)

    

 Non-Hispanic white Americans

69 (59.0)

179 (79.6)

 Hispanic Americans

39 (33.3)

34 (15.1)

 African Americans

9 (7.7)

12 (5.3)

 Chinese – Han ethnicity

198 (79.2)

196 (80.0)

 Chinese – Zhuang/Yao ethnicity

52 (20.8)

49 (20.0)

  2-sided P

0.0002

0.83

Level of education (%)

    

 Below high school

22 (18.8)

17 (7.6)

115 (46.0)

102 (41.6)

 High School graduates

32 (27.3)

51 (22.7)

79 (31.6)

87 (35.5)

 Some college/occupational school

40 (34.2)

75 (33.3)

39 (15.6)

33 (13.5)

 College graduates or above

23 (19.7)

82 (36.4)

17 (6.8)

23 (9.4)

  2-sided P

0.001

0.47

Cigarette smoking

    

 Non- or long ex-smokers

70 (59.8)

162 (72.0)

141 (56.4)

161 (65.7)

 Current or recent ex-smokers

47 (40.2)

63 (28.0)

109 (43.6)

84 (34.3)

 <20 cigarettes/day

14 (12.0)

26 (11.6)

33 (13.2)

28 (11.4)

 ≥20 cigarettes/day

33 (28.2)

37 (16.4)

76 (30.4)

56 (22.9)

  2-sided

0.03

0.09

No. alcoholic drinks/day

    

 Nondrinkers

35 (29.9)

74 (32.9)

158 (63.2)

205 (83.7)

 <3

28 (23.9)

110 (48.9)

60 (24.0)

31 (12.7)

 ≥3

54 (46.2)

41 (18.2)

32 (12.8)

9 (3.7)

  2-sided P

<0.0001

<0.0001

Hepatitis B serology

    

 Negative

84 (71.8)

198 (88.0)

45 (18.0)

212 (86.5)

 Anti-HBc positive only

30 (25.6)

27 (12.0)

 HBsAg positive

3 (2.6)

0

205 (82.0)

33 (13.5)

  2-sided P

0.0002

<0.0001

Hepatitis C serology

    

 Anti-HCV negative

59 (50.4)

224 (99.6)

241 (96.4)

242 (98.8)

 Anti-HCV positive

58 (49.6)

1 (0.4)

9 (3.6)

3 (1.2)

  2-sided P

<0.0001

0.09

Hepatitis B/C serology

    

 Both negative

54 (46.2)

198 (88.0)

45 (18.0)

210 (85.7)

 Either positive†

63 (53.9)

27 (12.0)

205 (82.0)

35 (14.3)

  2-sided P

<0.0001

<0.0001

  1. * Anti-HBC, antibodies to hepatitis B core antigen; HBsAg, hepatitis B surface antigen; anti-HCV, antibodies to hepatitis C virus.
  2. † Positive for hepatitis B surface antigen, antibodies to the hepatitis B surface antigen (for Los Angeles subjects only), or antibodies to hepatitis C virus.